theless, other factors, particularly the adrenergic system, may contribute to myocardial hypertrophy rr),
Introduction
cm, was used together with a fibre optic recorder, (Honeywell), paper speed 50 mm/s.
---
Echocardiogram was recorded in the supine a 'standard area', by the same investigator. Each echocardiogram was examined in a blind fashion by two observers, and no significant difference was found between their readings.
The left hypertrophy 'Onsequent to position with the patient lying on the left side in arterial hypertension is mainly due to the increase in left ventricular wall tension, which in turn depends upon left ventricular pressure and dimension, according to Laplace's law [ 11. NeverCorrespondence: Professor Angel0 Cherchi, 8, Via The following details were obtained from the records: systolic and diastolic arterial pressures Is Mirrionis, 09100 Cagliari, Italy. 368s F. Sau, A . Cherchi and C . Seguro (SBP, DBP) heart rate (HR), left ventricular enddiastolic dimension (EDD) at the peak of the R wave of the simultaneously recorded ECG, endsystolic dimension (ESD, as the minimal distance between the edges of septa1 and posterior wall endocardium), interventricular septum thickness (IVST), posterior wall thickness (PWT 
Results
The body weight was not significantly changed, compared with control (72.8 k SE 2.5 kg), after 1 month (72.0 f 2.4 kg; P > 0.05) or after 1 year (73.0 f 2.6 kg; P > 0.05) of atenolol treatment.
Haemodynamic and echocardiographic data are reported in Table 1 .
Systolic and diastolic blood pressures and heart rate were reduced, in comparison with control, both after 1 month and after 1 year of treatment, without significant differences between these two periods.
The reduction of arterial pressure was mainly due to a decrease in cardiac output; total vascular resistance did not change significantly after 1 month or 1 year of treatment.
The decrease of cardiac output was essentially referable to the reduction of heart rate, as the stroke volume was slightly but significantly increased after 1 month and again was not significantly different from control values after 1 year. The end-diastolic dimension of the left ventricle was increased after 1 month in relation to the heart rate decrease and reverted to pretreatment values after 1 year, in spite of persistent bradycardia.
The left ventricular mass was decreased after 1 year of treatment and this was due to a reduction of both interventricular septum and posterior wall thickness. The mean wall stress was unchanged after 1 month and 1 year of treatment.
The hlR ratio was unchanged after 1 month, and significantly reduced after 1 year, indicating that left ventricular hypertrophy had reversed.
Moreover, the fractional shortening of the left ventricle was normal in the control state (38.2 & 1.5%) and showed no significant changes after 1 month (37-7 k 1.7%; P > 0.05) or 1 year of treatment (38.4 k 1.4%; P > 0.05). Similarly, the mean velocity of circumferential shortening of the left ventricle (mean VCF), was normal at control (1.28 f 0.6 circ./s) with no significant modifications after 1 month (1.17 f 0.06 circ./s; P > 0.05) or 1 year of treatment (1 -16 k 0.04 circ./s; P > 0.05). Therefore atenolol seems to have no significant influence on left ventricular performance.
Discussion
Antihypertensive drugs seem to influence hypertensive myocardial hypertrophy differently.
In spontaneously hypertensive rats, the left Moreover, the left ventricle's mass was found to be unchanged after diuretics alone or in combination with sympatholytic drugs I 121.
This research has shown that atenolol, a /3-adrenoceptor blocking agent, reverses hypertensive left ventricle hypertrophy, reducing thickness of the wall of the left ventricle. The reduction of left ventricular mass did not seem to correlate with the decrease of left ventricular stress, which was unchanged after treatment, in spite of arterial pressure reduction. After 1 month of treatment, the reduction of arterial pressure was counterbalanced by the increase of left ventricular dimension, and after 1 year by the decrease of left ventricular wall thickness.
Therefore the reduction of left ventricular mass could be due mainly to the decrease of adrenergic activity [2, 7] .
In conclusion, hypertensive left ventricular hypertrophy can be reversed after long-term antihypertensive treatment, at least in relatively young people. Atenolol, a selective P-adrenergic blocking agent, reduces myocardial mass, decreasing left ventricular wall thickness.
